Seacondary data from Northern Areas of Pakistan>Medicinal Plants >Marketing of Medicinal Plants



Introduction

Forest and Rangelands

Medicinal Plants
Survey of medicinal plants in Northern Areas
Threats to medicinal plants
Potential of medicinal plants
Marketing of medicinal plants
Sea buckthorn – a valuable medicinal plant
Success stories
Gaps in data
Wildlife
Freshwater
Climate Change
Summary and Recommendations

Marketing of Medicinal Plants

An AKRSP research report on availability and marketing of medicinal plants by Iqbal Hussain, President, AMHRWO.

This section is based on material contained in Hussain (2004). According to this report, Pakistan has a wide floral diversity containing 600 taxa. A conservative approach indicates that 700 species are being used as medicinal/ aromatic plants. It further states that the total number of plant species in the Hindu Kush, Himalayas and Karakorum is estimated to be 25,000 or 10 percent of the world of which about 10,000 are useful. About 60 percent of the population in Pakistan uses herbal medicines. About 350 medicinal plants are found in wild. Around 100 of these are collected and sold by local hakims (healers), plant collectors and dealers. Twenty species are supplied to the national market, mainly Lahore and Karachi.

This study has short listed the following fifteen commercially important medicinal plants based on the following criteria: the endemic nature of plant, high domestic as well as export demand, endangered nature and documented use in traditional system of medicines.

Artemisia maritiama, Aconitum napellus, Angelica glauca, Bergenia himalacia, Carum carvi, Carthamus tinctorious, Dactylorrhiza hatagirea, Ephedra gerardiana, Glycyrrhiza glabra, Hyppopha rhamnoides, Picrorhizza kurrooa, Podophylum emodi, Sussurea lappa, Thymus serphylum, Valeriana walllichii

Collection

Medicinal plants are collected in the wild, purchased by traders and sold to exporters or to industry. They are exported in crude form i.e. in the form of roots, bark, seeds, leaves and branches. However, there is no systematic method for medicinal plant collection in Northern Areas. Local collectors simply collect whatever they find in the pasture. Wholesalers hire local people and pay them Rs. 80 to 100 daily for collection or barter them consumable products.

The collectors have a small share in the profit as they have little bargaining power and few options of marketing their products. They accept whatever is offered to them. The following table shows that the wholesalers earn a profit ranging from 250 to 650 times the price which the collectors receive:

Table Profit received by collectors and wholesalers of medicinal plants

Name of plant Collector rate (Rs.) National market rate (Rs.) International market rate (Rs.)
Aconitum napellus 120 500 3000
Bergenia himalacia 25 250 1500
Carum carvi 200 400-500 2000
Carthamus tinctorious 150 500 1500
Dactylorrhiza hatagirea ------ 500/ 1250 7000
Ephedra gerardiana 5 25 800
Glycyrrhiza glabra 10 30 1200
Hyppopha rhamnoides 45 300 500
Picrorhiza kurrooa 200 ------ 4500
Podophylum emodi 150 400 500
Sussurea lappa 150 150 2500
Thymus serphylum 35 150 1500
Valeriana walllichii -------- 500 5000

Source: Hussain, I. 2004. A research report on availability and marketing of medicinal plants. Market Development Section, Aga Khan Rural Support Program.

Medicinal plant marketing linkages workshop at Bulashbar and Shinaki valleys

To boost the marketing of locally available medicinal plants on a sustainable basis WWF-Pakistan, under the Northern Areas Conservation Project, arranged a two day workshop from June 21-22, 2002 on Marketing Linkage of Medicinal Plants at Bulashbar valley, Astore and Shinaki valley, Hunza (WWF-Pakistan, 2002). The aim was to chalk out ways and means for the marketing of potential medicinal plants in both areas. For this purpose three local wholesalers/ local hakims were contacted to assist the communities in identifying economically valued plants.
The participants and local dealers/ communities discussed the issues regarding marketing, middleman threats and commercially important plants. Eighteen economically and medicinally important plants were identified that presently are being provided to the wholesalers by Shinaki and Astore communities. The following information was collected for each species:

Table . Information on medicinal plants from Shinaki and Astore

Plant species Existing market price (Rs.) Availability on commercial scale (community perspective)
Artemisia absintium (Shinaki /Astore) 50 Yes
Sussurea lappa (Astore) 50-60 No
Berberis lyceum (Astore/ Shinaki) 25-30 (roots and bark) Yes
Caparris spinosa (Shinaki) 180 (seeds) 30-40 (whole plant) --------
Onosma bracteatum (Astore/ Shinaki) 130-140 No
Carum bulbocastanum (Astore) 200-250 (seeds) Yes
Peganum harmala (Shinaki) 110-130 (dried flowers) Yes
Valeriana walllichii (Shinaki) 80-90 --------
Ephedra gerardiana (Shinaki/ Astore) 15-20 (dried plant) --------
Viola pilosa (Astore/ Shinaki) 120 (dried flower) --------
Thymus serphylum (Astore/ Shinaki) 30-50 (dried leaves ) Yes (Astore)
Valeriana jatamansii (Astore/ Shinaki) 70-80 (dried leaves) ------
Mentha sylvestres (Astore/ Shinaki) 20-30 dried leaves) Yes
Juniperus macropoda (Astore/ Shinaki) 40-60 (berries) Yes
Hyppophae rehmnoides (Shinaki/ Astore but in small quantities) 35-40 (dried berries) Yes (Shinaki)
Rumex hastatus (Astore/ Shinaki) 80-90 (whole dried plant) --------
Picrorhiza kurrooa (Astore) 180-200 (dried roots) No
Ferula narthex (Astore) 250-280 (resin) No
After discussion the dealers and communities came to the conclusion that Podophyllum emodi, Carum bulbocastanum, Ephedra gerardina, Artemisia absinthium and Hyppophae rehmnoides should be focused on for commercial production and extraction on a sustainable basis. However, Artemisia absinthium in Astore and sea buckthorn in Shinaki were recommended for commercial exploitation whereas the remaining three species were recommended for ex-situ and in-situ cultivation or regeneration. While discussing the future prospects of medicinal plant cultivation on farmlands the farmers showed reluctance because medicinal plants give low yield and low returns as compared to agronomic or horticultural crops.

Study conducted by Hassan Sher, WWF-Pakistan

This study was conducted, as described above, in the Ghulkin valley and the researcher recommended the following medicinal plants for marketing.
Table . Medicinal plants for marketing from Ghulkin valley

Botanical name Part sold Price per kg national level (Rs.) Export to
Cichorium intybus Roots/ seeds 60 India, Italy, Hong Kong
Berberis aitchisonii Roots 40 Middle East
Bunium persicum Fruits 350 Germany, south Korea, South Africa
Juniperus macropoda Fruits 2000 India
Onosma hispidum Roots 90 India, Europe
Plantago major Seeds 40 Korea, France
Rheum emodi Roots 80 Iran, Middle East
Rosa webbenia Flowers 150 Korea, India
Thymus serphyllum Leaves 80 Europe, Middle East
Juglans regia Fruite 50 Middle East, Europe
Source: Sher, H. 2002. Feasibility study on the medicinal plants of Ghulkin valley Gilgit Pakistan; sustainable resource use and bio-diversity conservation at key sites in the Northern Areas of Pakistan. Report. WWF-Pakistan, Northern Areas, Gilgit.

 

 

 

 
footer

© All photos, graphics and images on this site remain the copyright of WWF and should not be downloaded without prior agreement.